Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease.
Røseth
A G
AG
Aker University Hospital, Oslo, Norway. arnegur@online.no
Aadland
E
E
Grzyb
K
K
D000293:Adolescent; D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000032:analysis; D001707:Biopsy, Needle; D015331:Cohort Studies; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000628:therapy; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000175:diagnosis / Q000628:therapy; D016099:Endoscopy, Gastrointestinal; D005243:Feces / Q000737:chemistry; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis* / Q000628:therapy; D007413:Intestinal Mucosa / Q000473:pathology*; D039841:Leukocyte L1 Antigen Complex / Q000032:analysis / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011336:Probability; D011379:Prognosis; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D018709:Statistics, Nonparametric; D016896:Treatment Outcome
D015415:Biomarkers; D039841:Leukocyte L1 Antigen Complex